Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas. (Q50420224)
Jump to navigation
Jump to search
scientific article published in January 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas. |
scientific article published in January 2018 |
Statements
Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas (English)
Krzysztof Kałwak
Agnieszka Zaucha-Prażmo
Wanda Badowska
Andrzej Kołtan
Katarzyna Musioł
Małgorzata Janeczko-Czarnecka
Irena Karpińska-Derda
Maciej Niedźwiecki
Magdalena Ćwiklińska
Grażyna Karolczyk